MoneyWorks4Me

The sales for the March 2022 quarter moved down -31.40% to Rs. 149.82 millions as compared to Rs. 218.41 millions during the year ago period.The Net Loss for the quarter ended March 2022 is Rs. -10.15 millions as compared to Net Profit of Rs. 26.37 millions of corresponding quarter ended March 2021The Operating Profit of the company witnessed a decrease to 7.45 millions from 45.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 149.82 218.41 -31.40 851.40 712.18 19.55 851.40 712.18 19.55
Other Income 12.68 3.08 311.69 21.02 7.49 180.64 21.02 7.49 180.64
PBIDT 7.45 45.10 -83.48 135.94 110.47 23.06 135.94 110.47 23.06
Interest 1.68 3.75 -55.20 7.94 7.42 7.01 7.94 7.42 7.01
PBDT 3.86 41.35 -90.67 106.44 103.05 3.29 106.44 103.05 3.29
Depreciation 14.01 14.98 -6.48 54.93 44.78 22.67 54.93 44.78 22.67
PBT -10.15 26.37 -138.49 51.51 58.27 -11.60 51.51 58.27 -11.60
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -10.15 26.37 -138.49 51.51 58.27 -11.60 51.51 58.27 -11.60
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 4.97 20.65 -75.92 15.97 15.51 2.93 15.97 15.51 2.93
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..